Although there were issues that will need to be addressed such as the high number of patients that were p16-negative and the small number of patients in this study, we found that p16 could also be a predictive marker for chemoradiosensitivity in advanced ESCC. The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.